Bellanger et al. (2015), which perhaps is the most relevant of these studies, suggests that PBDEs along with other EDCs contribute substantially to neurobehavioral deficits and disease in the EU, with a high probability of >150 billion euro costs/year.
Ainsi, la quasi-élimination est une solution parmi d'autres, et n'exclut pas l'élimination progressive ou l'interdiction de certaines substances lorsque cela se justifieUN-2 UN-2